Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Algorithms for Crohn’s Disease
Michael Christian Sulz, Emanuel Burri, Pierre Michetti, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 43-57
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease
Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, et al.
Dermatology Reports (2023)
Open Access | Times Cited: 5
Intestinal stricture in Crohn's disease: A 2020 update
Xiaoxuan Lin, Yun Qiu, Xiao Jun Zhuang, et al.
Journal of Digestive Diseases (2021) Vol. 22, Iss. 7, pp. 390-398
Closed Access | Times Cited: 12
Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells
Xuyan Tian, Lipeng Tang, Fengjiao Wei, et al.
Molecular Immunology (2021) Vol. 132, pp. 30-40
Closed Access | Times Cited: 11
Medical, Endoscopic and Surgical Management of Stricturing Crohn’s Disease: Current Clinical Practice
Fotios S. Fousekis, Ioannis V. Mitselos, Kostas Tepelenis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2366-2366
Open Access | Times Cited: 8
Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURN
Michelle Vu, Sabyasachi Ghosh, Kandavadivu Umashankar, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease
David Schöler, Karel Kostev, Maximilian Peters, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4586-4586
Open Access | Times Cited: 7
Long-Term Outcome of Surgery for Perianal Crohn’s Fistula
M. W. Schaad, Alain Schoepfer, Jean‐Benoît Rossel, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1035-1035
Open Access | Times Cited: 1
Evaluation of Selenium Concentrations in Patients with Crohn’s Disease and Ulcerative Colitis
Michał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 1
Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil
Milton Artur Ruiz, Roberto Luiz Kaiser, Lílian Piron-Ruiz, et al.
World Journal of Stem Cells (2020) Vol. 12, Iss. 10, pp. 1113-1123
Open Access | Times Cited: 7
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
Sara Salvador‐Martín, Alejandra Melgarejo-Ortuño, Luis A. López‐Fernández
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1786-1786
Open Access | Times Cited: 6
Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease
Lola Holcomb, Johanna Holman, Molly Hurd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study
Domingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, et al.
Gastroenterología y Hepatología (2023) Vol. 47, Iss. 1, pp. 51-62
Open Access | Times Cited: 2
Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?
Muhammed Bahaddin Durak, Cem Şimşek, Bayram İnan, et al.
International Journal of Colorectal Disease (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 2
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
Niloofar Khoshnam Rad, Homayoon Vahedi, Anahita Sadeghı, et al.
Middle East Journal of Digestive Diseases (2023) Vol. 15, Iss. 2, pp. 83-106
Open Access | Times Cited: 2
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s Disease
Madeline Alizadeh, Osman Ali, Raymond K. Cross
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 788-794
Open Access | Times Cited: 2
Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months
Niels Teich, H Grümmer, Eric Jörgensen, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta
Fabián Juliao Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, et al.
Revista Colombiana de Gastroenterología (2020) Vol. 35, Iss. Supl. 2, pp. 63-200
Open Access | Times Cited: 4
Doença de Crohn - uma revisão abrangente sobre a epidemiologia, fisiopatologia e patogênese, fatores de risco, diagnóstico clínico, diagnóstico imagiológico, manifestações extra intestinais, tratamento, nutrição e dieta
Olívia Mazzini Baêta, Ana Karen Alves, Júlia Marques Moreno, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 4, pp. 17438-17454
Open Access | Times Cited: 1
Enhancing surgical precision: unveiling the impact of preoperative colonoscopy in anal fistula patients
Shumin Xu, Luo Zhang, Zhi Li, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study
Domingo Balderramo, Jesús K. Yamamoto‐Furusho, Enrique Ponce de León, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 1, pp. 51-62
Open Access
Long-term efficacy of vedolizumab therapy in patients with Crohn’s disease
E. S. Peda, B. А. Nanaeva, O. V. Knyazev, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 9, pp. 34-41
Open Access
Doença de Crohn - uma revisão abrangente sobre etiologia, epidemiologia, diagnóstico, tratamento farmacológico e tratamento cirúrgico
Rachel Barros Pinheiro, Arthur Kalil Santana Nasser, Clarice Roman Nascimento e Silva, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 3, pp. e69402-e69402
Open Access
Upadacitinib en una paciente con enfermedad de Crohn con pérdida de respuesta a ustekinumab: reporte de un caso
E.F. Coronado-Rivera, C.E. Alcántara-Figueroa
Revista de Gastroenterología de México (2024) Vol. 89, Iss. 3, pp. 449-450
Open Access
A Novel Treatment of Crohn’s Disease that is Not Only Safe in Pregnancy but Can Correct Infertility and Recurrent Miscarriages
Jerome H. Check, Diane Check, Brooke Neumann
Gynecology & Reproductive Health (2024) Vol. 8, Iss. 2
Open Access
The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study
Patrick Gagnon‐Sanschagrin, Myrlene Sanon, M. Davidson, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 931-940
Open Access

Scroll to top